WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002030866) NITRODERIVATIVES AS DRUGS FOR DISEASES HAVING AN INFLAMMATORY BASIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/030866    International Application No.:    PCT/EP2001/011664
Publication Date: 18.04.2002 International Filing Date: 09.10.2001
Chapter 2 Demand Filed:    11.04.2002    
IPC:
A61K 31/21 (2006.01), A61K 31/44 (2006.01), C07C 203/04 (2006.01), C07C 233/25 (2006.01), C07C 317/46 (2006.01), C07C 323/60 (2006.01), C07D 213/30 (2006.01)
Applicants: NICOX S.A. [FR/FR]; 2455, route des Dolines Espace Gaia II - Bâtiment I F-06906 Sophia Antipolis Cedex (FR) (For All Designated States Except US).
DEL SOLDATO, Piero [IT/IT]; (IT) (For US Only).
BENEDINI, Francesca [IT/IT]; (IT) (For US Only).
ANTOGNAZZA, Patrizia [IT/IT]; (IT) (For US Only)
Inventors: DEL SOLDATO, Piero; (IT).
BENEDINI, Francesca; (IT).
ANTOGNAZZA, Patrizia; (IT)
Agent: SAMA, Daniele; Sama Patents Via G.B. Morgagni, 2 I-20129 Milano (IT)
Priority Data:
MI2000A002202 12.10.2000 IT
Title (EN) NITRODERIVATIVES AS DRUGS FOR DISEASES HAVING AN INFLAMMATORY BASIS
(FR) NITRODERIVES UTILES EN TANT QUE MEDICAMENTS DESTINES A DES MALADIES D'ORIGINE INFLAMMATOIRE
Abstract: front page image
(EN)Use for the treatment of diseases having an inflammatory basis of compounds or salts thereof, having the following general formula (I): A-X¿1?-L-(W)¿p?-NO¿2? wherein A contains the radical of a drug, X¿1? and W are bivalent radicals, L is a covalent bond or oxygen, sulphur, NR¿1c? wherein R¿1c? is H or a C¿1?-C¿5? linear or branched alkyl.
(FR)L'invention concerne l'utilisation, dans le traitement de maladies d'origine inflammatoire, de composés ou sels de ceux-ci, possédant la formule générale A-X¿1?-L-(W)¿p?-NO¿2? (I) dans laquelle A contient le radical d'un médicament, X¿1? et W représentent des radicaux bivalents, L représente une liaison covalente ou oxygène, soufre ou NR¿1c? où R¿1c? représente H ou un alkyle C¿1?-C¿5? linéaire ou ramifié.
Designated States: AE, AG, AL, AU, BA, BB, BG, BR, BZ, CA, CN, CR, CU, CZ, DM, DZ, EE, GD, GE, HR, HU, ID, IL, IN, IS, JP, KP, KR, LC, LK, LR, LT, LV, MA, MG, MK, MN, MX, NO, NZ, PL, RO, SG, SI, SK, TR, TT, UA, US, UZ, VN, YU, ZA.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)